Wexford Capital’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8M | Buy |
3,608,081
+7,529
| +0.2% | +$30.8K | 4.12% | 3 |
|
|
2025
Q1 | $6.19M | Hold |
3,600,552
| – | – | 1.61% | 13 |
|
|
2024
Q4 | $5.28M | Hold |
3,600,552
| – | – | 0.84% | 17 |
|
|
2024
Q3 | $6.16M | Hold |
3,600,552
| – | – | 1.47% | 14 |
|
|
2024
Q2 | $7.64M | Hold |
3,600,552
| – | – | 1.93% | 9 |
|
|
2024
Q1 | $7.95M | Sell |
3,600,552
-82,172
| -2% | -$181K | 1.62% | 10 |
|
|
2023
Q4 | $12.7M | Sell |
3,682,724
-4,714
| -0.1% | -$16.3K | 2.73% | 3 |
|
|
2023
Q3 | $5.46M | Buy |
3,687,438
+29,973
| +0.8% | +$44.4K | 1.21% | 21 |
|
|
2023
Q2 | $5.67M | Hold |
3,657,465
| – | – | 1.13% | 26 |
|
|
2023
Q1 | $3.91M | Hold |
3,657,465
| – | – | 0.81% | 30 |
|
|
2022
Q4 | $4.24M | Hold |
3,657,465
| – | – | 0.87% | 22 |
|
|
2022
Q3 | $3.33M | Buy |
3,657,465
+2,354
| +0.1% | +$2.14K | 1.05% | 24 |
|
|
2022
Q2 | $175K | Sell |
3,655,111
-8,858
| -0.2% | -$423 | 9.98% | 4 |
|
|
2022
Q1 | $534K | Buy |
3,663,969
+13,440
| +0.4% | +$1.96K | 26.94% | 1 |
|
|
2021
Q4 | $647K | Buy |
+3,650,529
| New | +$647K | 26.99% | 1 |
|
|
2021
Q2 | $36.9M | Buy |
3,631,197
+66,667
| +2% | +$677K | 5.55% | 3 |
|
|
2021
Q1 | $23.7M | Buy |
3,564,530
+2,284
| +0.1% | +$15.2K | 3.54% | 3 |
|
|
2020
Q4 | $30.6M | Buy |
3,562,246
+166,667
| +5% | +$1.43M | 4.79% | 3 |
|
|
2020
Q3 | $24.6M | Hold |
3,395,579
| – | – | 6.57% | 2 |
|
|
2020
Q2 | $28.5M | Hold |
3,395,579
| – | – | 7.16% | 1 |
|
|
2020
Q1 | $21.4M | Buy |
+3,395,579
| New | +$21.4M | 7.91% | 1 |
|